Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan

Diabetic Medicine

Volumn 19, Issue 10, 2002, Pages 858-861

  Price, D A ^a   Lansang, M C ^a   Osei, S Y ^a   Fisher, N D L ^a   Laffel, L M B ^a   Hollenberg, N K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Diabetes; Obesity; Renal function; Renin

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANGIOTENSINOGEN; GLUCOSE; HEMOGLOBIN A1C; IRBESARTAN;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DIABETIC OBESITY; DISEASE DURATION; GLOMERULUS FILTRATION; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; NON INSULIN DEPENDENT DIABETES MELLITUS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SODIUM RESTRICTION; VASCULARIZATION;

ADULT; ANGIOTENSIN I; BIPHENYL COMPOUNDS; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OBESITY; RECEPTORS, ANGIOTENSIN; RENAL CIRCULATION; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; TETRAZOLES; VASODILATOR AGENTS;

EID: 0036400374     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00806.x     Document Type: Article

References (16)

1. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462.
2. De'Oliveira JM, Price DA, Fisher NDL, Allan DR, McKnight JA, Williams GHet al. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney Int 1997; 52: 771-777.
3. Price DA, Porter LE, Gordon M, Fisher NDL, De'Oliveira JMF, Laffel LMB et al. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 1999; 10: 2382-2391.
4. Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 2000; 49: 1367-1373.
5. Frederich RC Jr, Kahn BB, Peach MJ, Flier JS. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992; 19: 339-344.
6. Tamura K, Tanimoto K, Ishii M, Murakami K, Fukamizu A. Proximal and core DNA elements are required for efficient AGT promotor activation during adipogenic differentiation. J Biol Chem 1993; 268: 15024-15032.
7. Murakami E, Hiwada K, Kokubu T. Effects of insulin and glucagon on production of renin substrate by the isolated rat liver. J Endocrinol 1980; 85: 151-153.
8. Cassis LA. Down regulation of the renin-angiotensin system in streptozotocin-diabetic rats. Am J Physiol 1992; 262: E105-E109.
9. Shoback DM, Williams GH, Hollenberg NK, Davies RO, Moore TJ, Dluhy RG. Endogenous Ang II as a determinant of sodium modulated changes in tissue responsiveness to Ang II in normal man. J Clin Endocrinol Metab 1983; 57: 764-770.
10. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995; 95: 948-953.
11. Forrester T, McFarlane N, Bennet F, Wilks R, Puras A, Cooper R et al. AGT and blood pressure among blacks: findings from a community survey in Jamaica. J Hypertens 1996; 14: 315-321.
12. Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M et al. Plasma AGT concentrations in obese patients. Am J Hypertens 1997; 10: 629-633.
13. Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin MC, Skuppin Jet al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 1996; 14: 199-207.
14. Ingelfinger JR, Dzau VJ. Molecular biology of renal injury: emphasis on the role of the renin-angiotensin system. J Am Soc Nephrol Suppl 1991; 2: 9-20.
15. Ravid M, Lang R, Rachmani R, Lishner M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: a 7-year follow-up study. Arch Intern Med 1996; 156: 286-289.
16. Kambham N, Markowitz GS, Valeri AM, D'Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509.